Destination

2025-03-11

Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.

Read more...

[...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

blogspot

2024-11-08

Ahrefs vs SEMrush: Which SEO Tool Should You Use?

SEMrush and Ahrefs are among<br /> the most popular tools in the SEO industry. Both companies have been in<br /> business for years and have thousands of customers per month.<br /> & [...]

Match Score: 59.51

Destination

2025-03-07

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 51.29

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 46.87

Destination

2025-03-14

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]

Match Score: 46.76

Destination

2025-02-18

Paperplane Therapeutics raises $1.5M to treat anxiety and pain with medical VR

Paperplane Therapeutics has raised $1.5 million to treat patients for pain and anxiety using virtual reality. [...]

Match Score: 46.55

Destination

2025-03-10

Novo Nordisk's Ozempic successor disappointed Wall Street again

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more... [...]

Match Score: 44.03

Destination

2025-04-01

Here's how much Ozempic and similar drugs have soared in popularity since 2018

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.R [...]

Match Score: 43.19

Destination

2025-01-03

The best laptop you can buy in 2025

Laptops are evolving fast, with some new models harnessing AI-powered features that adapt to your usage and improve performance in real time. These AI PCs can optimize battery life, manage power acros [...]

Match Score: 37.82

Destination

2025-01-09

The new robot vacuums that caught our eye at CES 2025

CES is known for splashy TV and laptop launches, but in 2025, there were more than a few companies trying to make waves with robot vacuums, too. After years where it seemed like vacuuming, mopping, an [...]

Match Score: 37.41